Publication | Closed Access

Individualization of Immunosuppressive Therapy. III. Sirolimus Associated With a Reduced Incidence of Malignancy

Reduced IncidenceMedicineImmunosuppressive TherapyImmunologyTumor ImmunityImmune Checkpoint InhibitorImmunosuppressionImmunotherapyOncologyRadiation OncologyCancer ResearchSirolimus Associated